# URGN (UroGen Pharma Ltd.) - SEC EDGAR Financial Statements

> UroGen Pharma Ltd. reported $250.3M in revenue and a net loss of $65.75M for the trailing twelve months ended September 30, 2026 (up 223.9% year over year), with a 91.4% gross margin and a -12.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/URGN
- Markdown: https://convexityos.com/fundamentals/URGN.md
- SEC CIK: 0001668243
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:28 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001668243&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $250.3M | +223.9% YoY |
| Operating Income | TTM | -$30.94M | -12.4% margin |
| Net Income | TTM | -$65.75M | -26.3% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$132.0M | -52.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $91.92M | Total debt: $196.3M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $109.8M | $90.40M | $82.71M | $64.36M | $48.04M | $11.80M | $18K | $1.13M | $8.16M | $17.53M |
| Cost of Revenue | $12.45M | $8.88M | $9.36M | $7.65M | $5.16M | $1.01M | -- | $1.80M | $600K | $28K |
| **Gross Profit** | $97.34M | $81.52M | $73.35M | $56.70M | $42.88M | $10.79M | $18K | -$675K | $7.56M | $17.50M |
| Research & Development | $67.11M | $57.15M | $45.61M | $52.91M | $47.64M | $47.31M | $49.30M | $36.93M | $18.70M | -- |
| Selling, General & Admin | $155.1M | $121.2M | $93.27M | $82.84M | $87.53M | $90.22M | $60.20M | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $109.5M | $76.50M | $27.51M | -- |
| **Operating Income** | -$124.9M | -$96.78M | -$65.54M | -$79.04M | -$92.29M | -$126.7M | -$109.5M | -$77.18M | -$19.95M | $798K |
| **EBITDA** | -$124.6M | -$96.45M | -$64.73M | -$78.12M | -$91.46M | -$126.3M | -$109.2M | -$76.78M | -$19.75M | $998K |
| Interest Income | $5.96M | $8.90M | $2.64M | $938K | $365K | $1.99M | $4.62M | -- | -- | -- |
| Income Before Tax | -$153.4M | -$124.0M | -$98.32M | -$108.0M | -$109.4M | -$125.1M | -$105.1M | -$75.53M | -$19.98M | -$1.94M |
| Income Tax Expense | $78K | $2.83M | $3.92M | $1.75M | $1.45M | $3.37M | -- | $125K | $19K | -- |
| **Net Income** | -$153.5M | -$126.9M | -$102.2M | -$109.8M | -$110.8M | -$128.5M | -$105.1M | -$75.66M | -$20.00M | -$1.94M |
| Basic EPS | -$3.19 | -$2.96 | -$3.55 | -$4.81 | -$4.96 | -$5.90 | -$5.12 | -$4.80 | -$2.14 | -$1.91 |
| **Diluted EPS** | -- | -- | -- | -- | -$4.96 | -$5.90 | -$5.12 | -$4.80 | -$2.14 | -$1.91 |
| Basic Shares Outstanding | 48.1M | 42.9M | 28.8M | 22.8M | 22.3M | 21.8M | 20.5M | 15.8M | 9.7M | 2.3M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 22.3M | 21.8M | 20.5M | 15.8M | 9.7M | 2.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $89.00M | $72.46M | $50.96M | $37.84M | $27.48M | $24.21M | $20.25M | $24.57M |
| Cost of Revenue | $7.50M | $6.57M | $4.14M | $3.29M | $3.28M | $3.55M | $2.33M | $2.47M |
| **Gross Profit** | $81.50M | $65.88M | $46.82M | $34.55M | $24.20M | $20.66M | $17.92M | $22.09M |
| Research & Development | $25.96M | $17.34M | $15.60M | $14.31M | $14.01M | $18.91M | $19.87M | $14.89M |
| Selling, General & Admin | $47.21M | $48.44M | $51.49M | $39.35M | $37.58M | $43.20M | $34.97M | $34.86M |
| **Operating Income** | $8.33M | $111K | -$20.26M | -$19.11M | -$27.39M | -$41.45M | -$36.91M | -$27.66M |
| **EBITDA** | $8.43M | $211K | -$20.19M | -$19.04M | -$27.29M | -$41.35M | -$36.84M | -$27.59M |
| Interest Income | $681K | $946K | $931K | $908K | $1.18M | $1.68M | $2.20M | $2.81M |
| Income Before Tax | -$446K | -$8.72M | -$28.35M | -$26.64M | -$34.40M | -$48.92M | -$43.45M | -$34.86M |
| Income Tax Expense | $1.02M | $5.63M | -$4.77M | -$275K | -$1.05M | $1.01M | $392K | $2.65M |
| **Net Income** | -$1.46M | -$14.35M | -$23.57M | -$26.36M | -$33.35M | -$49.94M | -$43.84M | -$37.51M |
| Basic EPS | -$0.03 | -$0.28 | -$0.47 | -- | -$0.69 | -$1.05 | -$0.92 | -$0.80 |
| Basic Shares Outstanding | 50.6M | 50.4M | 50.2M | -- | 48.1M | 47.7M | 47.4M | 47.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $110.7M | $172.0M | $95.00M | $55.41M | $44.36M | $52.86M | $49.69M | $101.3M | $37.00M | $21.36M |
| Short-Term Investments | $49.31M | $110.7M | $56.16M | $44.56M | $44.78M | $49.15M | $97.39M | -- | $36.00M | -- |
| **Cash & Short-Term Investments** | $120.5M | $241.7M | $141.5M | $99.96M | $66.88M | $102.0M | $147.1M | $101.3M | $73.00M | $21.36M |
| Accounts Receivable, Net | $33.08M | $20.30M | $15.44M | $12.70M | $11.72M | $7.05M | -- | -- | -- | $83K |
| Inventory | $16.46M | $9.23M | $5.67M | $4.33M | $4.83M | $1.96M | -- | -- | $316K | $105K |
| **Total Current Assets** | $186.0M | $276.1M | $169.2M | $128.9M | $114.4M | $115.6M | $148.6M | $102.2M | $74.47M | $22.04M |
| Property, Plant & Equipment, Net | $637K | $655K | $689K | $1.30M | $1.97M | $2.05M | $977K | $948K | $805K | $741K |
| Long-Term Investments | $0 | $5.02M | $4.50M | $0 | $675K | $1.89M | $48.55M | -- | -- | -- |
| Other Non-Current Assets | $5.16M | $589K | $2.04M | $2.74M | $1.31M | $66K | $264K | $317K | $244K | $250K |
| **Total Non-Current Assets** | $14.43M | $9.58M | $9.12M | $6.71M | $5.36M | $6.39M | $53.75M | $1.32M | $1.08M | $1.01M |
| **Total Assets** | $200.5M | $285.7M | $178.3M | $135.6M | $119.7M | $122.0M | $202.4M | $103.6M | $75.55M | $23.06M |
| Accounts Payable | $12.14M | $10.93M | $6.51M | $5.53M | $5.79M | $3.27M | $4.69M | $4.27M | $2.84M | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | $650K | -- |
| Other Current Liabilities | $3.43M | $7.95M | $3.86M | $3.28M | $3.33M | $1.86M | $1.58M | -- | -- | -- |
| **Total Current Liabilities** | $46.42M | $45.95M | $31.21M | $23.92M | $22.38M | $21.44M | $19.48M | $13.46M | $7.04M | $3.14M |
| Long-Term Debt | $122.2M | $121.7M | $98.55M | $97.54M | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $259.5M | $248.6M | $212.3M | $201.1M | $88.95M | $4.21M | $2.60M | $0 | $0 | $3.61M |
| **Total Liabilities** | $305.9M | $294.5M | $243.5M | $225.0M | $111.3M | $25.65M | $22.09M | $13.46M | $7.04M | $6.75M |
| **Total Debt (incl. Leases)** | $130.1M | $125.5M | $101.1M | $100.1M | $1.49M | $2.70M | $4.19M | -- | -- | -- |
| Common Stock | $133K | $115K | $89K | $63K | $61K | $60K | $57K | $44K | $37K | $6.0K |
| Retained Earnings | -$959.7M | -$806.2M | -$679.3M | -$577.1M | -$467.3M | -$356.5M | -$228.0M | -$122.9M | -$47.21M | -$27.21M |
| Accumulated Other Comp. Income | $19K | $56K | $12K | -$107K | -$25K | $271K | $276K | -- | -- | -- |
| **Total Stockholders' Equity** | -$105.5M | -$8.80M | -$65.21M | -$89.36M | $8.41M | $96.36M | $180.3M | $90.09M | $68.52M | $16.31M |
| Total Equity | -$105.5M | -$8.80M | -$65.21M | -$89.36M | $8.41M | $96.36M | $180.3M | $90.09M | $68.52M | $16.31M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $85.56M | $79.13M | $110.0M | $110.7M | $90.04M | $92.90M | $104.0M | $172.0M |
| Short-Term Investments | $6.35M | $30.16M | $39.74M | $49.31M | $63.79M | $83.11M | $112.0M | $110.7M |
| **Cash & Short-Term Investments** | $90.50M | $108.0M | $140.3M | $120.5M | $127.4M | $161.6M | $200.4M | $241.7M |
| Accounts Receivable, Net | $117.3M | $88.76M | $55.41M | $33.08M | $19.70M | $19.65M | $19.64M | $20.30M |
| Inventory | $25.15M | $24.59M | $20.92M | $16.46M | $8.34M | $7.13M | $7.59M | $9.23M |
| **Total Current Assets** | $251.9M | $235.4M | $237.5M | $186.0M | $168.5M | $196.9M | $237.2M | $276.1M |
| Property, Plant & Equipment, Net | $588K | $597K | $616K | $637K | $695K | $688K | $627K | $655K |
| Long-Term Investments | -- | -- | -- | $0 | $380K | $4.63M | $4.51M | $5.02M |
| Other Non-Current Assets | $11.86M | $8.76M | $7.49M | $5.16M | $6.76M | $801K | $371K | $589K |
| **Total Non-Current Assets** | $19.98M | $17.16M | $16.23M | $14.43M | $16.50M | $11.85M | $10.44M | $9.58M |
| **Total Assets** | $271.9M | $252.6M | $253.7M | $200.5M | $185.0M | $208.7M | $247.6M | $285.7M |
| Accounts Payable | $17.26M | $15.47M | $17.21M | $12.14M | $10.28M | $13.56M | $14.57M | $10.93M |
| Other Current Liabilities | $8.14M | $7.62M | $5.45M | $3.43M | $4.96M | $4.94M | $4.71M | $7.95M |
| **Total Current Liabilities** | $74.03M | $61.91M | $50.63M | $46.42M | $42.24M | $47.55M | $42.00M | $45.95M |
| Long-Term Debt | $189.4M | $188.7M | $189.5M | $122.2M | $122.1M | $122.5M | $122.1M | $121.7M |
| **Total Non-Current Liabilities** | $323.1M | $323.1M | $327.3M | $259.5M | $258.2M | $254.5M | $252.1M | $248.6M |
| **Total Liabilities** | $397.1M | $385.0M | $377.9M | $305.9M | $300.5M | $302.1M | $294.1M | $294.5M |
| **Total Debt (incl. Leases)** | $196.3M | $196.1M | $197.1M | $130.1M | $129.9M | $127.5M | $126.4M | $125.5M |
| Common Stock | $135K | $135K | $134K | $133K | $128K | $126K | $126K | $115K |
| Retained Earnings | -$999.1M | -$997.6M | -$983.3M | -$959.7M | -$933.4M | -$900.0M | -$850.1M | -$806.2M |
| Accumulated Other Comp. Income | -$1.0K | -$2.0K | $8.0K | $19K | $23K | $6.0K | $14K | $56K |
| **Total Stockholders' Equity** | -$125.2M | -$132.4M | -$124.3M | -$105.5M | -$115.4M | -$93.38M | -$46.46M | -$8.80M |
| Total Equity | -$125.2M | -$132.4M | -$124.3M | -$105.5M | -$115.4M | -$93.38M | -$46.46M | -$8.80M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$153.5M | -$126.9M | -$102.2M | -$109.8M | -$110.8M | -$128.5M | -$105.1M | -$75.66M | -$20.00M | -$1.94M |
| Depreciation & Amortization | $307K | $329K | $802K | $924K | $831K | $416K | $300K | $400K | $200K | $200K |
| Stock-Based Compensation | $11.96M | $13.11M | $9.34M | $10.58M | $23.11M | $28.02M | $29.97M | $30.64M | $6.30M | $1.97M |
| Change in Receivables | -$12.78M | -$4.86M | -$2.74M | -$987K | -$4.67M | -$7.05M | -- | -- | $83K | -$83K |
| Change in Inventory | -$7.24M | -$3.55M | -$1.35M | -$362K | -$2.87M | -$1.96M | -- | $316K | -$211K | -$105K |
| **Operating Cash Flow** | -$162.4M | -$96.77M | -$76.38M | -$87.56M | -$84.89M | -$105.9M | -$71.02M | -$37.33M | -$9.57M | $4.19M |
| Capital Expenditure | -$289K | -$295K | -$194K | -$254K | -$752K | -$1.22M | -$325K | -$560K | -$271K | -$695K |
| **Free Cash Flow** | -$162.7M | -$97.06M | -$76.57M | -$87.81M | -$85.64M | -$107.1M | -$71.34M | -$37.89M | -$9.84M | $3.49M |
| Purchases of Investments | -$77.40M | -$128.0M | -$49.83M | -$63.01M | -$51.90M | -$29.69M | -$197.7M | -- | -$36.00M | -- |
| Sales & Maturities of Investments | -- | -- | -- | $64.32M | $56.72M | $124.1M | -- | -- | -- | -- |
| **Investing Cash Flow** | $61.56M | -$20.61M | -$953K | $1.06M | $4.07M | $93.24M | -$145.6M | $35.29M | -$36.28M | -$719K |
| Common Stock Issued | $39.80M | $151.2M | $67.36M | $0 | $0 | $15.85M | $161.7M | $64.23M | $60.84M | -- |
| **Financing Cash Flow** | $39.92M | $194.6M | $116.9M | $97.13M | $72.32M | $16.53M | $165.2M | $66.42M | $61.59M | -$9.0K |
| **Net Change in Cash** | -$60.97M | $77.24M | $39.60M | $10.63M | -$8.50M | $3.88M | -$51.36M | $64.37M | $15.74M | $3.46M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.46M | -$14.35M | -$23.57M | -$26.36M | -$33.35M | -$49.94M | -$43.84M | -$37.51M |
| Depreciation & Amortization | $100K | $100K | $75K | $75K | $100K | $100K | $72K | $68K |
| Stock-Based Compensation | $6.25M | $5.33M | $4.63M | $3.13M | $3.03M | $2.73M | $3.07M | $3.30M |
| Change in Receivables | -$28.53M | -$33.34M | -$22.33M | -$13.38M | -$54K | -$11K | $664K | $2.50M |
| Change in Inventory | -$561K | -$3.67M | -$4.46M | -$8.12M | -$1.21M | $462K | $1.64M | -$1.63M |
| **Operating Cash Flow** | -$15.20M | -$33.01M | -$45.32M | -$38.33M | -$42.27M | -$39.83M | -$42.02M | -$13.62M |
| Capital Expenditure | -$72K | -$60K | -$54K | -$17K | -$87K | -$141K | -$44K | -$115K |
| **Free Cash Flow** | -$15.27M | -$33.07M | -$45.37M | -$38.34M | -$42.36M | -$39.97M | -$42.07M | -$13.73M |
| Purchases of Investments | $0 | $0 | -$24.78M | -$539K | -$8.72M | -$1.79M | -$66.35M | -$9.23M |
| **Investing Cash Flow** | $19.85M | $1.67M | -$20.69M | $27.72M | $31.40M | $28.41M | -$25.96M | $60.62M |
| Common Stock Issued | -- | -- | $0 | $31.83M | $7.97M | -$4.0K | $4.0K | $0 |
| **Financing Cash Flow** | $1.78M | $500K | $65.20M | $31.32M | $8.27M | $296K | $34K | $71K |
| **Net Change in Cash** | $6.43M | -$30.83M | -$800K | $20.71M | -$2.60M | -$11.12M | -$67.95M | $47.07M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 88.7% | 90.2% | 88.7% | 88.1% | 89.3% | 91.4% | 100.0% | -59.8% | 92.6% | 99.8% |
| **Operating Margin** | -113.7% | -107.1% | -79.2% | -122.8% | -192.1% | -1074.2% | -608211.1% | -6842.2% | -244.5% | 4.6% |
| **Net Profit Margin** | -139.8% | -140.4% | -123.6% | -170.6% | -230.7% | -1088.9% | -584144.4% | -6707.2% | -245.2% | -11.1% |
| Return on Equity (ROE) | -- | -- | -- | -- | -1317.2% | -133.3% | -58.3% | -84.0% | -29.2% | -11.9% |
| Return on Assets (ROA) | -76.6% | -44.4% | -57.3% | -80.9% | -92.5% | -105.3% | -52.0% | -73.1% | -26.5% | -8.4% |
| Current Ratio | 4.01x | 6.01x | 5.42x | 5.39x | 5.11x | 5.39x | 7.63x | 7.59x | 10.59x | 7.03x |
| Quick Ratio | 3.65x | 5.81x | 5.24x | 5.21x | 4.90x | 5.30x | 7.55x | 7.52x | 10.54x | 6.99x |
| Debt to Equity | -- | -- | -- | -- | 0.18x | 0.03x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | +21.4% | +9.3% | +28.5% | +34.0% | +307.2% | +65450.0% | -98.4% | -86.2% | -53.5% | -- |
| Gross Profit Growth (YoY) | +19.4% | +11.1% | +29.4% | +32.2% | +297.5% | +59844.4% | -- | -108.9% | -56.8% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -2600.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -328.4% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -381.6% | -- |
| 5Y Revenue / Share Growth | +321.2% | +240351.0% | +3906.4% | +236.1% | -71.7% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 91.4% | 90.8% | 89.9% | 88.7% | 88.0% | 88.5% | 89.7% | 90.2% |
| **Operating Margin** | -12.4% | -35.3% | -77.0% | -113.7% | -138.2% | -131.1% | -117.5% | -107.1% |
| **Net Profit Margin** | -26.3% | -51.7% | -94.8% | -139.8% | -170.6% | -164.4% | -150.7% | -140.4% |
| Return on Assets (ROA) | -24.2% | -38.7% | -52.5% | -76.6% | -89.0% | -74.2% | -55.9% | -44.4% |
| Current Ratio | 3.40x | 3.80x | 4.69x | 4.01x | 3.99x | 4.14x | 5.65x | 6.01x |
| Quick Ratio | 3.06x | 3.41x | 4.28x | 3.65x | 3.79x | 3.99x | 5.47x | 5.81x |
| **Revenue Growth (YoY)** | +223.9% | +199.2% | +151.6% | +54.0% | +9.0% | +10.8% | +7.8% | +4.4% |
| Gross Profit Growth (YoY) | +236.7% | +218.8% | +161.2% | +56.4% | +6.4% | +5.3% | +5.1% | +4.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
